204 related articles for article (PubMed ID: 10810184)
1. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS
Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
[TBL] [Abstract][Full Text] [Related]
2. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
Homer KL; Wanstall JC
Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
Severina IS; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
[TBL] [Abstract][Full Text] [Related]
7. Vasorelaxant and antiplatelet activity of 4,7-dimethyl-1,2, 5-oxadiazolo[3,4-d]pyridazine 1,5,6-trioxide: role of soluble guanylate cyclase, nitric oxide and thiols.
Kots AY; Grafov MA; Khropov YV; Betin VL; Belushkina NN; Busygina OG; Yazykova MY; Ovchinnikov IV; Kulikov AS; Makhova NN; Medvedeva NA; Bulargina TV; Severina IS
Br J Pharmacol; 2000 Mar; 129(6):1163-77. PubMed ID: 10725265
[TBL] [Abstract][Full Text] [Related]
8. The relaxant activity of 4,7-dimethyl-1,2,5-oxadiazolo[3,4-d]-pyridazine 1,5,6-trioxide in the mouse corpus cavernosum.
Göçmen C; Büyüknacar HS; Kots AY; Murad F; Kiroglu O; Kumcu EK
J Pharmacol Exp Ther; 2006 Feb; 316(2):753-61. PubMed ID: 16254132
[TBL] [Abstract][Full Text] [Related]
9. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
10. Guanidine thiol--a new activator of soluble guanylate cyclase with antihypertensive and antiaggregatory properties.
Severina IS; Bussygina OG; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1995 Jul; 36(4):913-25. PubMed ID: 8528155
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
[TBL] [Abstract][Full Text] [Related]
12. Nitrovasodilators and cGMP inhibit human platelet activation.
Doni MG; Alexandre A; Padoin E; Bertoncello S; Deana R
Cardioscience; 1991 Sep; 2(3):161-5. PubMed ID: 1660321
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
Karrenbrock B; Grewe R; Loeschke K; Gerzer R
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
[TBL] [Abstract][Full Text] [Related]
14. [A new activator of soluble guanylate cyclase generated by nitric oxide and having antihypertensive and anti-aggregation properties].
Busygina OG; Belushkina NN; Grigor'ev NB; Severina IS
Biokhimiia; 1995 Sep; 60(9):1460-7. PubMed ID: 8562654
[TBL] [Abstract][Full Text] [Related]
15. [Soluble platelet guanylate cyclase: significance of heme in regulating enzymatic activity and the role of the enzyme in platelet aggregation].
Severina IS
Biokhimiia; 1994 Mar; 59(3):325-39. PubMed ID: 7910045
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of human platelet aggregation by a new class of soluble guanylate cyclase inhibitor, generating nitric oxide].
Belushkina NN; Grigor'ev NB; Severina IS
Biokhimiia; 1994 Nov; 59(11):1689-97. PubMed ID: 7873676
[TBL] [Abstract][Full Text] [Related]
17. [Nitric oxide. The role of guanylate cyclase in its physiological effects].
Severina IS
Vopr Med Khim; 2002; 48(1):4-30. PubMed ID: 12068497
[TBL] [Abstract][Full Text] [Related]
18. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.
Severina IS
Biochemistry (Mosc); 1998 Jul; 63(7):794-801. PubMed ID: 9721331
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregation.
Gudmundsdóttir IJ; McRobbie SJ; Robinson SD; Newby DE; Megson IL
Biochem Biophys Res Commun; 2005 Nov; 337(1):382-5. PubMed ID: 16185664
[TBL] [Abstract][Full Text] [Related]
20. Activation of guanylate cyclase and the regulatory role of cyclic 3',5'-guanosine monophosphate.
Severina IS
Biochem Int; 1988 Aug; 17(2):265-78. PubMed ID: 2903739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]